Study of Fibromatosis Stem Cells in Mice
Author Information
Author(s): Wang Jung-Pan, Hui Yun-Ju, Wang Shih-Tien, Yu Hsiang-Hsuan Michael, Huang Yi-Chao, Chiang En-Rung, Liu Chien-Lin, Chen Tain-Hsiung, Hung Shih-Chieh
Primary Institution: National Yang-Ming University, Taipei, Taiwan
Hypothesis
Can fibromatosis stem cells (FSCs) be isolated and used to model fibromatosis in mice?
Conclusion
FSCs can recapitulate human fibromatosis nodules in mice and may serve as a model for developing new treatments.
Supporting Evidence
- FSCs can be isolated from fibromatosis nodules but not from normal tissues.
- FSCs express specific surface markers indicating their stem cell nature.
- Implanted FSCs formed fibromatosis-like nodules in mice.
- TSA treatment inhibited FSC proliferation and differentiation.
- FSCs demonstrated multipotentiality to differentiate into various cell types.
Takeaway
Scientists found special cells from fibromatosis that can grow into tumors in mice, helping us understand this disease better.
Methodology
FSCs were isolated from patients and implanted in mice to study their behavior and response to treatment.
Potential Biases
Potential bias in the selection of patients and the small sample size.
Limitations
The model only reflects subcutaneous fibromatosis and may not fully represent human conditions.
Participant Demographics
Patients included 6 individuals with palmar fibromatosis, aged 46 to 85, with a mix of genders.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website